Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

TSX:TRIL - Post Discussion

Trillium Therapeutics Inc. > $24 USD target by Analyst
View:
Post by winemerlotcab67 on Jan 23, 2020 3:47pm

$24 USD target by Analyst

Do your own DD

Happy Investing
Comment by winemerlotcab67 on Apr 22, 2020 1:15pm
great call so far :-)
Comment by birch1 on Apr 22, 2020 1:17pm
Yes sir.  
Comment by birch1 on Apr 22, 2020 1:26pm
Probably back to $9 in a week or so.  Hope they get a bid like Forty Seven did and probably for more.
Comment by burnout29 on Apr 30, 2020 5:46pm
This post has been removed in accordance with Community Policy
Comment by birch1 on May 01, 2020 2:56pm
Nice action for a friday in the US for sure.
Comment by birch1 on May 04, 2020 1:50pm
Good action again today.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities